NCM Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
NCM Capital Management's LLY Position: Q2 2026 in Review
NCM Capital Management reduced its Eli Lilly (LLY) stake by 0.51% in Q2 2026, selling an estimated $15.3K and leaving 2,914 shares worth $3.49M. The position accounts for 1.08% of the portfolio, ranked #17.
NCM Capital Management first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- NCM Capital Management held 2,914 shares of Eli Lilly worth $3.49M as of Q2 2026.
- NCM Capital Management sold 15 Eli Lilly shares in Q2 2026, an estimated $15.3K.
- Eli Lilly made up 1.08% of NCM Capital Management's portfolio in Q2 2026, its #17 holding.
- NCM Capital Management first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on NCM Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.